DoD Peer Reviewed Orthopaedic, Women's Health Research Award
ID: 354135Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Peer Reviewed Orthopaedic, Women's Health Research Award (WHRA) to support research focused on orthopaedic injuries affecting women, particularly those serving in military roles. This funding opportunity aims to address significant health disparities and promote recovery for female service members who sustain orthopaedic injuries, with an emphasis on studies that demonstrate relevance to military or veteran populations. The total estimated funding for this program is $3 million, with approximately two awards anticipated, each with a maximum budget of $1.5 million. Interested applicants must submit pre-applications by August 21, 2024, and full applications by September 17, 2024. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    Files
    Title
    Posted
    The DOD FY24 Peer Reviewed Orthopaedic Women’s Health Research Award (WHRA) aims to support research focused on women’s health in relation to orthopaedic injuries, particularly among military personnel. This funding opportunity seeks to address significant gaps in care and promote recovery and rehabilitation for women who sustain injuries during service. Applications are encouraged to explore the unique health conditions affecting women and their specific treatment needs. The program has a total budget of $30 million for FY24, aiming to fund approximately two projects with a maximum budget of $1.5 million per award. Key deadlines for application submission are August 21, 2024, for pre-applications and September 17, 2024, for full applications. Eligible applicants include domestic and foreign organizations, including not-for-profits and academic institutions. Research projects must demonstrate a clear connection to military or veteran populations and must adhere to strict guidelines regarding study design and analysis plans. This opportunity aligns with federal initiatives to enhance women’s health research, ensuring impactful studies contribute to the well-being of female service members. The review process will prioritize scientific merit, potential military benefits, and the qualifications of the research team.
    Similar Opportunities
    DoD Peer Reviewed Orthopaedic, Applied Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army's USAMRAA is offering the FY24 Peer Reviewed Orthopaedic Applied Research Award, aimed at funding applied research to enhance care for military personnel suffering from combat-related orthopaedic injuries. The program seeks innovative solutions that can translate into clinical applications, focusing on areas such as limb stabilization and battlefield care strategies, while excluding pure basic research. With an estimated total funding of $3.75 million to support approximately five awards, each capped at $750,000 over a maximum three-year period, interested applicants must submit pre-applications by June 18, 2024, followed by full applications due by September 17, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Orthopaedic, Clinical Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Materiel Command (USAMRAA), is offering the Fiscal Year 2024 Peer Reviewed Orthopaedic Clinical Translational Research Award (CTRA) to support innovative research aimed at addressing significant gaps in orthopaedic care, particularly for military personnel with combat-related injuries. This funding opportunity encourages proposals that focus on enhancing treatment options and rehabilitation strategies for orthopaedic injuries, with an emphasis on interdisciplinary collaboration and clinical relevance. The total estimated funding for this program is $6 million, with a maximum award amount of $1.5 million per project, and applications are due by September 17, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Peer Reviewed Orthopaedic, Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the Fiscal Year 2024 (FY24) Peer Reviewed Orthopaedic Clinical Trial Award aimed at enhancing recovery from combat-related orthopaedic injuries. This grant supports clinical trials that focus on innovative treatment strategies, including limb stabilization, battlefield care, and rehabilitation, with an emphasis on interdisciplinary collaboration to improve military readiness and patient care. With an estimated total program funding of $13.25 million, the program anticipates awarding up to four grants of $2.5 million each for standard projects and one grant of $3.25 million for collaborative care projects. Interested applicants must submit pre-applications by June 18, 2024, and full applications by September 17, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org.
    DoD Arthritis, Focused Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the DoD Arthritis Focused Research Award (Funding Opportunity Number: HT942524ATRPFRA) to support innovative research aimed at improving patient care for individuals affected by arthritis. This grant encourages applications that explore high-risk, high-reward research addressing various types of arthritis, including osteoarthritis and rheumatoid arthritis, with a particular focus on the implications for military personnel and their families. The total funding available for FY24 is approximately $2.5 million, with individual project budgets capped at $750,000 for Research Level 2 and $500,000 for Research Level 1. Interested applicants must submit a pre-application by October 16, 2024, and a full application by October 30, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Combat Readiness - Medical, Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Combat Readiness - Medical Translational Research Award (CRRP TRA) to support high-impact translational research aimed at enhancing medical readiness for military personnel. This funding opportunity seeks proposals that address critical areas such as battlefield diagnostics, treatments for life-threatening injuries, and operational health threats, with an emphasis on projects that leverage existing resources and demonstrate clear relevance to military health. The total estimated funding for this initiative is approximately $3.3 million, with the expectation of awarding around three grants, and key deadlines include pre-applications due by September 4, 2024, and full proposals by December 5, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    Military Health System Research Program Notice of Funding Opportunity
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), has announced a Notice of Funding Opportunity (NOFO) for the Military Health System Research Program (MHSRP), aimed at enhancing research capabilities within the Military Health System (MHS). This program invites applications for research projects that focus on healthcare economics, quality, outcomes, variations, health readiness, and the impacts of policy changes, with the goal of fostering innovative health system research that supports both military and civilian healthcare. The total estimated funding for this initiative is $10 million, with applications due by September 20, 2024, following a Letter of Intent submission by June 10, 2024. Interested applicants can reach out to the DHA MHSR Program Mailbox at dha.ncr.j-9.mbx.hsr@health.mil for further information.
    DoD Reconstructive Transplant, Advanced Technology Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Reconstructive Transplant Advanced Technology Development Award, aimed at supporting innovative research in reconstructive transplantation for injured Service Members and Veterans. This grant opportunity encourages the development of products such as drugs, biologic agents, and clinical practice guidelines, with a focus on enhancing techniques and access to reconstructive transplantation. The program has an estimated total funding of $3.5 million, with awards of up to $1.5 million available for applications involving multiple principal investigators. Interested applicants must submit a pre-application by August 7, 2024, followed by a full application due by October 23, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Arthritis Research, Clinical Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Arthritis Research Clinical Research Award (ATRP CRA) to support clinical research aimed at improving the understanding and management of various forms of arthritis, particularly in military personnel and their families. This grant program encourages innovative research proposals that address disease-specific factors and interventions, with a focus on enhancing patient outcomes and informing clinical care or policy. With an estimated total funding of $6 million, the program anticipates awarding approximately three grants, including one for a clinical trial, with applications due by October 30, 2024, and a pre-application deadline of October 16, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Reconstructive Transplant Research, Investigator-Initiated Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is inviting applications for the FY24 Reconstructive Transplant Research Program (RTRP) Investigator-Initiated Research Award, aimed at advancing reconstructive transplant research and improving healthcare for military service members and veterans. This grant opportunity seeks proposals that focus on vascularized composite allotransplantation (VCA) and immunotherapy, emphasizing the optimization of immunosuppressive techniques, identification of noninvasive biomarkers for graft rejection monitoring, and development of tissue preservation strategies. With an estimated total program funding of $4 million, individual principal investigator applications can receive up to $1 million, while multiple principal investigator collaborations may secure up to $1.5 million, contingent upon successful peer review. The pre-application deadline is August 7, 2024, and the full application deadline is October 23, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Reconstructive Transplant, Qualitative Research Validation and Implementation Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Reconstructive Transplant, Qualitative Research Validation and Implementation Award, aimed at advancing qualitative research in reconstructive transplantation. This grant seeks to validate and implement resources developed from previous studies related to vascularized composite allotransplantation (VCA), focusing on improving outcomes for service members, veterans, and the broader community. The total funding available for this opportunity is $500,000, with a maximum budget for individual projects capped at the same amount, and applications are due by October 23, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.